Project schedule

Project Indication Mechanism research Drug design Experimentation PCC

nNOS Pathway Disruptors

Neurodegenerative diseases

ER PROTAC

Breast cancer

GCGR Inhibitors

Treatment of Type II Diabetes

PCNA Inhibitors

Solid tumors

BRD4 Inhibitors

Lung cancer, breast cancer,
leukemia, liver cancer, multiple myeloma